Growing Market Presence With recent participation in major healthcare conferences such as the Citi Global Healthcare Conference and CNS Annual Meeting, the company is actively engaging with industry leaders and expanding its visibility in the medical technology sector. This creates opportunities to promote innovative products and strengthen partnerships.

Strong Industry Recognition Being recognized as a top employer and a leader in healthcare technology for 2024 enhances the company's credibility, making it an attractive partner for hospitals and clinics seeking reliable and award-winning medical solutions.

Expanding Product Portfolio Acquisition of the ACell portfolio and the wide array of regenerative and surgical products positioned within the company suggests potential sales opportunities in soft tissue repair, wound management, and reconstructive surgery markets.

Innovation and R&D Investment The company’s integration of advanced technologies like Cytal Wound Matrix and MicroMatrix UBM, coupled with ongoing participation in research and industry events, indicates a focus on developing cutting-edge products that can meet unmet clinical needs, opening doors for innovative sales pitches.

Customer Engagement & Support Despite recent recall issues, the company's active engagement in addressing challenges and its extensive global presence suggest ongoing opportunities to provide support, training, and service enhancements to healthcare providers, fostering long-term relationships.